Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?

British Journal of Radiology

Volumn 75, Issue 894, 2002, Pages 514-517

  Ott, M ^a   Breiter, N ^a   Albrecht, C F ^a   Pradier, O ^a   Hess, C F ^a   Schmidberger, H ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DISEASE ACTIVITY; EXTRAOCULAR MUSCLE; EYE DISEASE; FEMALE; FIBROSIS; GRAVES DISEASE; HUMAN; IMAGE ANALYSIS; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPERTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT; PREDICTION; RADIATION RESPONSE; RELIABILITY; RETROSPECTIVE STUDY; SOFT TISSUE; SYMPTOM;

EID: 0036336152     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.75.894.750514     Document Type: Article

References (24)

1. Place of radiotherapy in the treatment of Graves' orbitopathy
2. Low-versus high-dose radiotherapy for Graves' ophthalmopathy: A randomized, single blind trial
3. Radiotherapy for Graves' orbitopathy: Randomised placebo-controlled study
4. Prognostic factors in the radiotherapy of Graves' ophthalmopathy
5. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry
6. Retinopathy after irradiation for Graves' ophthalmopathy
7. Modification of the classification of the eye changes of Grave's disease: Recommendations of the ad hoc committee of the American Thyroid Association
8. Cigarette smoking and treatment outcomes in Graves ophthalmopathy
9. Effect of abnormal thyroid function on Graves' ophthalmopathy
10. Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy
11. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy
12. Immunology of Graves' ophthalmopathy
13. Graves' disease of the orbit
14. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: A novel approach
15. Graves orbitopathy: Correlation of CT and clinical findings
16. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance
17. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: Its predictive value for therapeutic outcome of immunosuppressive therapy
18. Relationships of orbital computed tomographic findings and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalmopathy
19. MRI in Graves orbitopathy: Recognition of enlarged muscles and prediction of steroid response
20. Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy
21. MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy
22. Extraocular muscles in Graves ophthalmopathy: Usefulness of T2 relaxation time measurements
23. Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids
24. Graves ophthalmopathy: Role of MR imaging in radiation therapy